Investigational Treatment for Food Allergies Request More Information Trial Objective Our researchers are trying to determine if a study medication called omalizumab alone or combined with oral immunotherapy may help people with multiple food allergies. Participants must have a peanut allergy and at least two other food allergies to milk, egg, wheat, cashew, hazelnut, or walnut. Enrollment Active Clinical Trials Currently Recruiting Who Can Participate Anyone between the ages of 1-55 years who has a peanut allergy and at least two other food allergies to milk, egg, wheat, cashew, hazelnut or walnut. Age: Not Specified Gender: Any Gender Estimated Time Commitment This is a multi-stage study, with an individual study participation of up to 4 years and 8 months, but not past December 2023. × Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit. Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study. Payment & Reimbursement Payment: Provided Travel Reimbursement: Not Available Trial Contact For more information, contact: Susan Leung 303.398.1549 Request More Information Trial Location National Jewish Main Campus, Denver, CO Trial Sponsors National Institute of Allergy and Infectious Diseases (NIAID) Principal Investigators Donald Leung, PhD, MD + × Donald Leung, PhD, MD Distinguished Professor Head, Division of Pediatric Allergy & Immunology Department of Pediatrics View Full Profile Make an Appoinment Co-Investigators Bruce Lanser, MD, MPH + × Bruce Lanser, MD, MPH Assistant Professor Director, Pediatric Food Allergy Program Director, Pediatric Allergy Fellowship Program Department of Pediatrics Division of Allergy & Clinical Immunology View Full Profile Make an Appoinment Mark Boguniewicz, MD + × Mark Boguniewicz, MD Professor Division of Pediatric Allergy & Clinical Immunology Department of Pediatrics View Full Profile Patient Rating 4.8 out of 5 stars Make an Appoinment Request More Information By completing this form, you agree to learn more about this study and see if you qualify. First Name:* Last Name:* Email Address:* Phone:* I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health: YesNo
Trial Objective Our researchers are trying to determine if a study medication called omalizumab alone or combined with oral immunotherapy may help people with multiple food allergies. Participants must have a peanut allergy and at least two other food allergies to milk, egg, wheat, cashew, hazelnut, or walnut.